The changes in the cardiac lesions of a patient dying with acute rheumatic heart disease treated with cortisone are reported. at times it appears to be life saving. The significance of this clinical response in terms of any true alteration of the long-term course of the illness cannot as yet be ascertained. Many years of study will be required to determine if permanent damage to the heart valves and myocardium has been prevented or measurably reduced.
The day after admission, the patient was started on 100 mg. of cortisone intramuscularly every eight hours. This dosage was continued until the patient died, at which time she had received a total of 3,200 mg. Her temperature gradually rose, reaching 105.6 F. on the fourth hospital day. She was started on 300,000 units of procaine penicillin intramuscularly every eight hours, and 0.6 Gm. acetyl salicylic acid every four hours. Within two days the temperature had declined to 102 F. but she continued to run a low grade fever of 100 to 101 F. until death. Demerol, mercurial diuretics, aminophyllin and intramuscular lanatoside C were used in an attempt to control her congestive heart failure and severe dyspnea. Her ventricular rate remained uncontrolled. Hydration was maintained by the administration of 500 cc. of 5 per cent glucose in water at frequent intervals, with 0.5 to 1.0 Gm. of potassium chloride added on several occasions. The patient continued to have periodic episodes of pulmonary edema.
A fecal impaction became obvious on March 29, 1952, despite the fact that she had had occasional bowel movements. It was impossible manually to reach the area of impaction and frequent oil enemas were unsuccessful. The abdomen became distended and the patient became moribund. The cardiac rhythm became completely regular with a ventricular rate of 180 per minute. She died shortly thereafter, with evidence of ventricular tachycardia and fibrillation, on the eleventh hospital day.
Pathologic Findings
Autopsy was performed two and one-half hours post mortem. The An occasional minute area of valvular endocarditis was noted near the attachment of the chordae tendineae, consisting of slight disruption of the endothelial surface and surrounding proliferation of connective tissue elements. These lesions also appeared to be of considerable standing. The tricuspid valve displayed minimal thickening by fibrous connective tissue and slight vascularization.
The lungs revealed an extensive passive congestion and patchy edema. In some areas, the alveolar septa were thickened by fibrous tissue. Other areas showed focal fibrinoid necrosis of septa with alveolar hemorrhage and fibrin deposition simulating the appearance of an asphyxial membrane. Many deposits of fibrin were undergoing organization and others were completely replaced by fibrous tissue. The recent changes in the alveolar septa were associated with a moderate interstitial infiltration of mononuclear phagocytes and lymphocytes and occasionally polymorphonuclear leukocytes. No abnormalities were noted in branches of the pulmonary arteries.
The adrenal glands revealed a marked cortical atrophy, involving principally the zona fasciculata. A moderate degree of medial cystic necrosis was encountered in the aorta. Sections of the spleen, pancreas, liver, kidneys, lymph nodes and bone marrow were not remarkable except for passive congestion.
Anatomic Diagnoses. Rheumatic heart disease, acute and chronic, with pericarditis, endocarditis and massive myocarditis; cardiac hypertrophy (350 Gm.); rheumatic pneumonitis; passive congestion of viscera; pleural effusion, bilateral; adrenal cortical atrophy; medial cystic necrosis of aorta; fecal impaction. We are unable to evaluate the effect of the morphologic alterations we have observed on the eventual fate of the lesions. Our patient received adrenocorticotropic hormone and cortisone early in her illness, but no change was apparent in the older myocardial lesions. They differed in no way from those seen in rheumatic myocarditis not treated with these hormones. Experimental observations suggest that withdrawal of hormone therapy may be quickly followed by an inflammatory cell infiltration into areas of collagen degeneration and the usual sequence of healing.10 Prolonged suppression of inflammatory reaction, however, might result in decreased scar tissue formation when final healing has occurred. The significance of our observations will have to be determined by the long-term studies now in progress of patients with rheumatic heart disease who have been treated successfully with adrenocorticotropic hormone and cortisone.
DISCUSSION

SUMMARY
Morphologic alterations were observed in the lesions of acute rheumatic myocarditis in a patient receiving large doses of cortisone. The changes consisted of a striking lack of cellular reaction to extensive interstitial collagen degeneration. Myocardial lesions which appeared to be of longer duration displayed varying degrees of healing and did not differ from those seen in rheumatic myocarditis not treated with adrenocorticotropic hormone or cortisone.
SUMARIO EsPAROL
Los cambios en las lesiones cardiacas en un paciente que muere con una carditis reumatica tratado con cortisona se reportan. Los cambios indican que el efecto de la hormona en los tejidos consiste en una inhibici6n de la reacci6n inflamatoria sin alteracion demostrable del dafio colageno.
